2-(2-methoxy-4-methylphenyl)aminoethane | 139102-20-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(2-methoxy-4-methylphenyl)aminoethane
• 英文别名: 2-(2-Methoxy-4-methyl-phenyl)-ethylamine；2-(2-methoxy-4-methylphenyl)ethanamine
• CAS: 139102-20-8
• 化学式: C₁₀H₁₅NO
• mdl: MFCD08450331
• 分子量: 165.235
• InChiKey: MJUPKSHVRMHWMF-UHFFFAOYSA-N

物化性质

• 沸点：
  258.8±25.0 °C(Predicted)
• 密度：
  0.994±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  2-甲氧基-4-甲基苯甲醛 在 乙酸铵 、 lithium aluminium tetrahydride 作用下， 以 乙醚 为溶剂， 反应 90.0h， 生成 2-(2-methoxy-4-methylphenyl)aminoethane
  参考文献：
  名称：

  Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity

  摘要：

  Certain phenylalkylamine derivatives have been considered to bind selectively at 5-HT2 serotonin receptors. It is now recognized that the most widely used derivatives, i.e., 1-(2,5-dimethoxy-4-X-phenyl)-2-aminopropanes where X = Me (DOM), Br (DOB), and I (DOI) (1-3, respectively) also bind at the more recently identified population of serotonin 5-HT1C receptors. The purpose of the present investigation was to determine whether simple phenylalkylamines bind selectively at one population of receptors over the other. An examination of 34 derivatives reveals (i) similar structure-affinity relationships and (ii) a significant correlation (r = > 0.9, n = 25) between 5-HT1C and 5-HT2 affinity. None of the compounds included in the present study displayed more than a 10-fold selectivity for one population of these receptors over the other; the results suggest that these compounds (including the widely used 5-HT2 agonists DOB and DOI) are 5-HT1C/5-HT2 agents.

  DOI：

  10.1021/jm00082a014

文献信息

• [EN] 4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZINES AS MODULATORS OF GPR139<br/>[FR] 4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZINES UTILISÉES EN TANT QUE MODULATEURS DE GPR139
  申请人：TAKEDA PHARMACEUTICAL

  公开号：WO2016081736A1

  公开（公告）日：2016-05-26

  The present invention provides a method for treating a disease, disorder or condition associated with GPR139 using compounds of formula (1), which are agonists of GPR139, certain compounds encompassed by formula (1), pharmaceutical compositions thereof, processes for making the compounds, and intermediates thereof.

  本发明提供了一种用式（1）的化合物治疗与GPR139相关的疾病、障碍或病症的方法，该化合物是GPR139的激动剂，式（1）所包含的某些化合物，其制药组合物，制造该化合物的过程以及其中间体。
• 4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZINES AS MODULATORS OF GPR139
  申请人：Takeda Pharmaceutical Company Limited

  公开号：EP3221298A1

  公开（公告）日：2017-09-27
• Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity
  作者：Richard A. Glennon、Reva Raghupathi、Piotr Bartyzel、Milt Teitler、Sigrun Leonhardt

  DOI：10.1021/jm00082a014

  日期：1992.2

  Certain phenylalkylamine derivatives have been considered to bind selectively at 5-HT2 serotonin receptors. It is now recognized that the most widely used derivatives, i.e., 1-(2,5-dimethoxy-4-X-phenyl)-2-aminopropanes where X = Me (DOM), Br (DOB), and I (DOI) (1-3, respectively) also bind at the more recently identified population of serotonin 5-HT1C receptors. The purpose of the present investigation was to determine whether simple phenylalkylamines bind selectively at one population of receptors over the other. An examination of 34 derivatives reveals (i) similar structure-affinity relationships and (ii) a significant correlation (r = > 0.9, n = 25) between 5-HT1C and 5-HT2 affinity. None of the compounds included in the present study displayed more than a 10-fold selectivity for one population of these receptors over the other; the results suggest that these compounds (including the widely used 5-HT2 agonists DOB and DOI) are 5-HT1C/5-HT2 agents.